CBPO  China Biologic Products Inc.

Exchange

NASDAQ

Sector

Health Care

Industry

Biotechnology: Biological Products (No Diagnostic Substances)

Market Cap.

3.10B

Vuru Grade

72.45/100

Current Price

$116.50
-1.01 (-0.86%)

Growth Price

$39.66
Overvalued by 65.96%

Stability Price

$22.09
Overvalued by 81.04%

Company Metrics

  • P/E 35.63
  • P/S 10.54
  • P/B 8.17
  • EPS 3.27
  • Cash ROIC 27.80%
  • Cash Ratio 2.02
  • Dividend 0 / 0%
  • Avg. Vol. 245,174.00
  • Shares 26.61M
  • Market Cap. 3.10B

Company Description

China Biologic Products, Inc., a biopharmaceutical company, engages in the research, development, production, and manufacture of plasma-based pharmaceutical products in the People's Republic of China. It offers Human Albumin for the treatment of shock caused by blood loss trauma or burn; raised intracranial pressure caused by hydrocephalus or trauma; oedema or ascites caused by hepatocirrhosis and... more


Download 10 Years of Financial Statements:
Income Statement   Balance Sheet   Cash Flow

News

China Biologic Products Inc. Q1 Profit Advances 22%
Nasdaq - 5 hours ago
(RTTNews.com) - China Biologic Products Inc. ( CBPO ) released earnings for its first quarter that gained ground compared to the same period last year.
China Biologic Products Inc (CBPO) Announces Earnings Results - Web Breaking News
China Biologic Products Inc (CBPO) Releases Earnings Results, Beats ... - Market Digest
China Biologic Products, Inc. (NASDAQ:CBPO) Boasts An Average Rating Of 3.5
Enterprise Leader - 13 hours ago
Alpha One applies algorithm-based analytics for assessing a stock sentiment as per the published released on web channels. In this evaluation process, the group accesses the most relevant news platforms on a daily basis.
China Biologic Products, Inc. (NASDAQ:CBPO) ABR Of 1
Enterprise Leader - 11 hours ago
Analysts have a buy call on China Biologic Products, Inc. (NASDAQ:CBPO) stock. As of 2016-05-03, it had an ABR of 1. The rating is fixed on a scale of 1-5.
Baring Asset Management Ltd buys $15067728 stake in China Biologic Products ...
Market Digest - May 3, 2016
China Biologic Products Inc (CBPO) : Baring Asset Management Ltd scooped up 110,599 additional shares in China Biologic Products Inc during the most recent quarter end , the firm said in a disclosure report filed with the SEC on Apr 25, 2016.
China Biologic Products, Inc. (NASDAQ:CBPO) Basic Consolidated EPS At $4.4574 - Markets Daily
Zacks: Analysts Set $160.50 Price Target for China Biologic Products Inc ... - Web Breaking News
Zacks: Brokerages Set $160.50 Price Target for China Biologic Products Inc ...
The Vista Voice - Apr 17, 2016
China Biologic Products logo China Biologic Products Inc (NASDAQ:CBPO) has been given an average broker rating score of 1.00 (Strong Buy) from the three analysts that provide coverage for the stock, Zacks Investment Research reports.
Navellier & Associates Inc Decreases Stake in China Biologic Products Inc (CBPO)
The Vista Voice - Apr 13, 2016
China Biologic Products logo Navellier & Associates Inc lowered its stake in China Biologic Products Inc (NASDAQ:CBPO) by 43.0% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission.
Broker Roundup For China Biologic Products, Inc. (NASDAQ:CBPO) - Share Trading News
China Biologic Products Inc (CBPO) Downgraded by Zacks Investment Research to Sell
South Florida Hedge Fund Managers - Apr 5, 2016
China Biologic Products logo China Biologic Products Inc (NASDAQ:CBPO) was downgraded by Zacks Investment Research from a “hold” rating to a “sell” rating in a research note issued to investors on Monday, MarketBeat Ratings reports.
China Biologic Products Inc (CBPO) Lowered to Sell at Zacks Investment Research - The Vista Voice
China Biologic Products Inc (CBPO) Rating Lowered to Sell at Zacks Investment ... - MicroCap Magazine
Broker Changes For China Biologic Products, Inc. (NASDAQ:CBPO)
Risers & Fallers - Apr 29, 2016
Recently stock market analysts have updated their consensus ratings on shares of China Biologic Products, Inc. (NASDAQ:CBPO).
China Biologic Products Inc (CBPO) Downgraded to "Sell" at Zacks Investment ...
South Florida Hedge Fund Managers - Mar 29, 2016
China Biologic Products logo China Biologic Products Inc (NASDAQ:CBPO) was downgraded by Zacks Investment Research from a “hold” rating to a “sell” rating in a report issued on Tuesday, Analyst Ratings Network.
Coupland Cardiff Asset Management Llp adds China Biologic Products Inc (CBPO ... - Street Edition
China Biologic Products Breaks Above 200-Day Moving Average - Bullish for CBPO - Nasdaq
China Biologic Products Inc (CBPO) Stock Rating Upgraded by Zacks Investment ...
The Vista Voice - Apr 14, 2016
China Biologic Products logo China Biologic Products Inc (NASDAQ:CBPO) was upgraded by Zacks Investment Research from a “sell” rating to a “hold” rating in a report released on Thursday, Analyst Ratings Net reports.
China Biologic Products Inc (NASDAQ:CBPO) Receives Consensus Rating of "Strong ... - Mas Market News
Hot Stock List: CorMedix, Inc. (NYSEMKT:CRMD), China Biologic Products, Inc ... - Stock Transcript